PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
61.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.39%
Negative gross profit growth while 1097.HK is at 46.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
-399.43%
Negative EBIT growth while 1097.HK is at 41.16%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.34%
Negative operating income growth while 1097.HK is at 39.97%. Joel Greenblatt would press for urgent turnaround measures.
-714.16%
Negative net income growth while 1097.HK stands at 35.01%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-713.16%
Negative EPS growth while 1097.HK is at 35.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-713.16%
Negative diluted EPS growth while 1097.HK is at 35.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share change of 0.00% while 1097.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.24%
Negative OCF growth while 1097.HK is at 12.22%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
45.21%
FCF growth above 1.5x 1097.HK's 14.16%. David Dodd would verify if the firm’s strategic investments yield superior returns.
178562.95%
Positive 10Y revenue/share CAGR while 1097.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
178.11%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
28.80%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
366.34%
Positive long-term OCF/share growth while 1097.HK is negative. John Neff would see a structural advantage in sustained cash generation.
321.78%
Positive OCF/share growth while 1097.HK is negative. John Neff might see a comparative advantage in operational cash viability.
216.09%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
79.08%
Positive 10Y CAGR while 1097.HK is negative. John Neff might see a substantial advantage in bottom-line trajectory.
83.79%
Positive 5Y CAGR while 1097.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-129.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-35.33%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
23.77%
Positive 5Y equity/share CAGR while 1097.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-0.97%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.18%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
0.13%
Asset growth well under 50% of 1097.HK's 0.60%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.66%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-7.72%
We’re deleveraging while 1097.HK stands at 15.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.